Boehringer Ingelheim says it is on track to launch 25 new treatments in its human pharma division onto the market between now and 2030, fuelled by an R&D pipeline that it says is the best in its ...

Forbes' latest edition of its Fresh Take newsletter features former Boar's Head employees and what they call the meat producer's intimidating retail strategy.

Bayer and Boehringer Ingelheim both had new data on their HER2-targeting small-molecule drugs to present at the World Conference on Lung Cancer (WCLC), hoping to add new oral therapies to the ...

Chloe Veltman is a correspondent on NPR's Culture Desk. From her base in San Francisco where she has lived for more than 20 years, Veltman covers a wide array of cultural news and trends, with a ...

Chloe Berger is a reporter on Fortune's Success team. She developed her understanding of employee rights and strategies for retaining new talent while working at the New York City Employment and ...

This evening will see largely clear skies with a few patches of light cloud lingering in places. Overnight, conditions will not change significantly but mist and fog could locally develop ...